Announced
Completed
Synopsis
BioDue, a consolidated industrial and commercial enterprise oriented towards the research, development, production and commercialization of cosmetic products, medical devices and food supplements, completed the acquisition of the remaining 57% stake in Farcoderma, which produces food supplements, cosmetics and medical devices. Financial terms were not disclosed. The transaction is consistent with the development strategy, including through external growth, defined together with the shareholders of control of Fondo Armònia and FIDIM.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.